Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Nephros (NEPH) over the last 16 years, with Q3 2025 value amounting to -$85000.0.

  • Nephros' Other Working Capital Changes rose 2272.73% to -$85000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$333000.0, marking a year-over-year increase of 2869.38%. This contributed to the annual value of $11886.0 for FY2024, which is 10347.54% up from last year.
  • Latest data reveals that Nephros reported Other Working Capital Changes of -$85000.0 as of Q3 2025, which was up 2272.73% from -$305000.0 recorded in Q2 2025.
  • Nephros' 5-year Other Working Capital Changes high stood at $137000.0 for Q1 2025, and its period low was -$305000.0 during Q2 2025.
  • Over the past 5 years, Nephros' median Other Working Capital Changes value was -$89000.0 (recorded in 2021), while the average stood at -$90578.9.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first tumbled by 26250.0% in 2021, then skyrocketed by 20960.0% in 2025.
  • Quarter analysis of 5 years shows Nephros' Other Working Capital Changes stood at -$89000.0 in 2021, then grew by 6.74% to -$83000.0 in 2022, then decreased by 26.51% to -$105000.0 in 2023, then increased by 23.81% to -$80000.0 in 2024, then dropped by 6.25% to -$85000.0 in 2025.
  • Its Other Working Capital Changes was -$85000.0 in Q3 2025, compared to -$305000.0 in Q2 2025 and $137000.0 in Q1 2025.